These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15711905)

  • 1. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 2. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 3. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating hypercholesterolemia aggressively.
    Wilson CS
    Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 8. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Wong ND; Lopez V; Tang S; Williams GR
    Am J Cardiol; 2006 Jul; 98(2):204-8. PubMed ID: 16828593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hypercholesterolemia revisited.
    Wiggins BS
    Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 12. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 18. [AFCAPS/TexCAPS [The Air Force/Texas Coronary Atherosclerosis Prevention Study]].
    Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():398-403. PubMed ID: 11347102
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.